TickerFacts.

Teva Pharmaceutical Industries Ltd (TEVA): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

$1.15B
Year ended 2025-12-31
$1.35B
Trailing 12 months to 2026-06-30
+3.3%
3-year compound annual growth
+12.5%
5-year compound annual growth
-13.3%
10-year compound annual growth
$4.77B2007-12-31: $1.27B2008-12-31: $2.55B2009-12-31: $2.65B2010-12-31: $3.43B2011-12-31: $3.08B2012-12-31: $3.47B2013-12-31: $2.21B2014-12-31: $4.20B2015-12-31: $4.77B2016-12-31: $2.99B2017-12-31: $1.35B2018-12-31: $1.79B2019-12-31: $223.00M2020-12-31: $638.00M2021-12-31: $236.00M2022-12-31: $1.04B2023-12-31: $842.00M2024-12-31: $749.00M2025-12-31: $1.15B$1.15B
2007-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$1.15B+53.3%2026-02-03, From 2025-01-01
2024-12-31$749.00M-11.0%2026-02-03, From 2024-01-01
2023-12-31$842.00M-19.2%2026-02-03, From 2023-01-01
2022-12-31$1.04B+341.5%2025-02-05, From 2022-01-01
2021-12-31$236.00M-63.0%2024-02-12, From 2021-01-01
2020-12-31$638.00M+186.1%2023-02-10, From 2020-01-01
2019-12-31$223.00M-87.6%2022-02-09, From 2019-01-01
2018-12-31$1.79B+32.9%2021-02-10, From 2018-01-01
2017-12-31$1.35B-54.8%2020-02-21, From 2017-01-01
2016-12-31$2.99B-37.3%2019-02-19, From 2016-01-07
2015-12-31$4.77B+13.6%2018-02-12, From 2015-01-01
2014-12-31$4.20B+90.3%2017-02-15, From 2014-01-01
2013-12-31$2.21B-36.4%2016-02-11, From 2013-01-01
2012-12-31$3.47B+12.6%2015-02-09, From 2012-01-01
2011-12-31$3.08B-10.1%2014-02-10, From 2011-01-01
2010-12-31$3.43B+29.1%2013-02-12, From 2010-01-01
2009-12-31$2.65B+4.1%2012-02-17, From 2009-01-01
2008-12-31$2.55B+100.6%2011-02-15, From 2008-01-01
2007-12-31$1.27Bn/a2010-02-22, From 2007-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Teva Pharmaceutical Industries Ltd (TEVA)2025-12-31$1.15B+53.3%
Regeneron Pharmaceuticals, Inc. (REGN)2025-12-31$4.08B+11.3%
Viatris Inc (VTRS)2025-12-31$1.94B-2.0%
Vertex Pharmaceuticals Inc (VRTX)2025-12-31$3.19Bn/m
Bausch Health Companies Inc. (BHC)2025-12-31$1.00B-20.4%
Zoetis Inc. (ZTS)2025-12-31$2.28B-0.7%
Abbott Laboratories (ABT)2025-12-31$7.39B+16.4%
Organon & Co. (OGN)2025-12-31$538.00M-29.6%
Bristol Myers Squibb Co (BMY)2025-12-31$12.85B-7.9%

Compare TEVA, REGN, VTRS, VRTX side by side · Screen every company in Pharmaceutical Preparations ↗